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Abstract
Background: The observation of cytokeratins (CK’s) in mass spectrometry based studies raises the question of
whether the identified CK is a true endogenous protein from the sample or simply represents a contaminant. This
issue is especially important in proteomic studies of the corneal epithelium where several CK’s have previously
been reported to mark the stages of differentiation from corneal epithelial stem cell to the differentiated cell.
Methods: Here we describe a method to distinguish very likely endogenous from uncertain endogenous CK’si na
mass spectrometry based proteomic study. In this study the CK identifications from 102 human corneal samples
were compared with the number of human CK identifications found in 102 murine thymic lymphoma samples.
Results: It was anticipated that the CK’s that were identified with a frequency of <5%, i.e. in less than one spot for
every 20 spots analysed, are very likely to be endogenous and thereby represent a ‘biologically significant’
identification. CK’s observed with a frequency >5% are uncertain endogenous since they may represent true
endogenous CK’s but the probability of contamination is high and therefore needs careful consideration. This was
confirmed by comparison with a study of mouse samples where all identified human CK’s are contaminants.
Conclusions: CK’s 3, 4, 7, 8, 11, 12, 13, 15, 17, 18, 19, 20 and 23 are very likely to be endogenous proteins if
identified in a corneal study, whilst CK’s 1, 2e, 5, 6A, 9, 10, 14 and 16 may be endogenous although some are likely
to be contaminants in a proteomic study. Further immunohistochemical analysis and a search of the current
literature largely supported the distinction.
Background
Cytokeratins (CK’s) belong to the family of intermediate
filaments, and are expressed in a variety of different cell
types, including those of the eye. CK’s can be classified
into type I (acidic) and type II (basic), and they often
appear together as pairs of these two types of proteins
[1,2]. Within the eye in particular, CK’s have been
shown to be important proteins with regard to cellular
development, proliferation and differentiation [3-7].
Proteomics using two-dimensional gel electrophoresis
(2D-PAGE) in combination with mass spectrometry
(MS) is often used as a screening tool in the search for
differentially expressed proteins [8]. If CK’sa r et h es u b -
ject of such an experiment, an important issue to
determine is whether the CK originates from the investi-
gated tissue or whether its presence is a consequence of
contamination from the laboratory environment.
As a consequence of the very high cell turn-over of
the surface epithelia the environment is contaminated
with cells from hair, skin, nails, eyebrows, eyelashes, air-
ways, etc. Furthermore, CK’s remain ubiquitous con-
taminants even in laboratories with very high cleaning
standards being extremely difficult to eliminate [9],
though their presence in MS laboratories should be
reduced as much as possible [10]. One way to diminish
the environmental contribution of CK’si st of i l t e ra l l
the liquids used for 2D-PAGE, including the reducing
agents [11] and to have efficient laboratory protocols to
maintain clean conditions in general [12].
In the search for stem cell markers, we previously
investigated the differences in protein expression
between the central corneal epithelium and the limbal
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identify proteins either highly expressed or exclusively
present in limbal epithelium[ 1 3 ] .T h el i m b u s ,w h i c hi s
located between the conjunctiva and the cornea, is a
niche for corneal epithelial stem cells. Several CK’s have
been proposed as markers of stem cells, transient ampli-
fying cells or differentiated cells [5,7,14]. Therefore, we
wanted to include biologically significant CKs in the
investigation in the search for limbal stem cell markers.
This study attempts to discuss whether it is possible
by a simple procedure to distinguish between very likely
endogenous and uncertain endogenous CK’s by counting
and evaluating all the human CK’s identified by mass
spectrometry in a human and murine study. These
results are compared with previous reports on location
and distribution of CK’s in the ocular surface tissue.
Further examination was performed by evaluating the
specific mass spectra of the cytokeratins in conjunction
with immunohistochemistry.
Methods
Human sample collection and preparation
Seven human eyes were obtained from The Institute of
Anatomy, Aarhus University within 48 hours post mor-
tem. The study adhered with the guidelines from the
local ethical committee and the tenets of the Declaration
of Helsinki. The eyes were carefully rinsed in sterile iso-
tonic saline and the epithelium was marked with 8 and
10 mm trephines prior to loosening the epithelium by
dabbing with 70% alcohol. Under clean conditions, the
corneal epithelium was gently scraped to separate the
central 8 mm epithelium. The intermediate epithelium
(8-10 mm ring) was discarded and the limbal fractions
were considered to be the epithelium scraped outside the
10 mm ring since, the conjunctival epithelium was not
able to be as easily loosend by this method. Both frac-
tions were transfered to lysis buffer, pH 3-10 NL [13].
Mouse sample collection and preparation
Two spontaneously developed thymic lymphomas, SM5
and SM7, from C57BL/6J-Trp53tm1Tyj mice deficient
for the p53 gene were explanted, in vitro cultured, and
established as cell lines growing in RPMI-1640 culture
medium supplemented with 10% fetal calf serum and
50 μM 2-mercaptoethanol. Freshly prepared thymocytes
obtained from pools of five mice (either C57BL/6J-
Trp53tm1Tyj or normal C57BL/6) and cultured SM5
and SM7 cells were washed extensively in PBS and sub-
sequently freeze dried. The cell pellets were dissolved in
lysis buffer, pH 3-10 NL [8].
2D-PAGE and MS identification
2D-PAGE and silver staining was performed as pre-
viously described [8,13]. The gels were re-hydrated and
the cellophane sheets peeled off prior to protein gel spot
excision. Gel pieces were dehydrated in acetonitrile,
dried and the proteins reduced for 1 h at 56°C in
10 mM dithiotreitol (DTT) and 100 mM NH4HCO3.
The solution was exchanged with 55 mM iodoacetamide
in 100 mM NH4HCO3 for 45 min. Gel pieces were then
washed in 100 mM NH4HCO3, dehydrated in acetoni-
trile, rehydrated in 100 mM NH4HCO3,d e h y d r a t e di n
acetonitrile, dried and swelled in digestion buffer
(50 mM NH4HCO3, 5 mM CaCl2 and 12.5 ng/μl trypsin
Gold (mass spectrometry grade; Promega, Madison, WI,
USA). The digestion was performed overnight at 37°C
prior to peptide extraction by 1 change of 20 mM
NH4HCO3 and 3 changes of 5% formic acid in 50%
acetonitrile. The sample was dried and peptides resus-
pended in buffer A (water/acetonitrile/formic acid, 97.7/
2/0.3, V/V/V). The peptides were separated on an inert
nano LC system of a Famos micro autosampler, a
Switchos micro column switching module and an Ulti-
mate micro pump from LC Packings (San Francisco,
CA) before MS analysis. Samples were concentrated and
desalted on a 300 μmi n n e rd i a m e t e rx5m mp r e c o l -
umn (LC Packings) packed with 5 μmC 1 8P e p M a p 1 0 0
material. A 75 μm inner diameter x 15 cm Nano col-
umn packed with 3 μm C18 PepMap100 material was
used to separate the peptides. Gradient elution from the
column was performed by mixing decreasing volumes of
buffer A with increasing volumes of buffer B (water/
acetonitrile/formic acid, 9.7/90/0.3, V/V/V). The pep-
tides were eluted into the nano electrospray ion source
of the quadrupole time-of-flight mass spectrometer
(Micromass, Manchester, UK). MS survey scans were
acquired using MassLynx 4 SP4 (Waters). The instru-
ment was operated in a data-dependent MS to MS/MS
switching mode. Doubly, triply and quadruply charged
peptide ions detected in MS survey scans triggered a
switch to MS/MS for obtaining peptide fragmentation
spectra. The processed data were used to search in the
Swiss-Prot Database (version 56.9) using the on-line ver-
sion of the Mascot MS/MS Ion Search facility (Matrix
Science, Ltd., http://www.matrixscience.com) [15].
Searching was performed with doubly and triply charged
ions with 2 missed cleavages, a peptide mass tolerance
of 50 ppm, one variable modification, Carbamido-
methyl-C and an MS/MS tolerance of ± 0.02 Da. Only
human proteins identified by bold red peptides were
regarded as significant and reported (excluding duplicate
homologous proteins).
Evaluation of the LC-MS/MS identifications
All significant human CK hits from the Mascot search
were counted in each sample of the human and mouse
s t u d y( T a b l e1 )a n dt h em a s ss p e c t r aw e r ee v a l u a t e d .
The CK’s were grouped as very likely endogenous
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endogenous (observed in more than 5% of the spots) on
the basis of the observed frequency in the human study.
Immunohistochemistry
Antibodies against CK 3/12 and 19 were obtained from
Chemicon (Billerica, MA), and antibodies for CK 15
were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). The immunohistochemical protocol has pre-
viously been published [13].
Statistical analyses
An unpaired non-parametric test (Mann-Whitney) was
performed to test for significant differences between CK
expression in the human and mouse studies.
Results and Discussion
We hypothesised that the higher the frequency that a
certain CK is identified by MS from a group of 2D-
PAGE spots the more likely it is to be a contaminating
protein. A set of 102 spots from the human study [13]
(Figure 1) was included in the investigation in conjunc-
tion with a set of 102 mouse spots [16]. In Table 1, CKs
are listed in two groups based on the observed fre-
quency of the CK in the human study; very likely endo-
genous (observed in less than 5% of the spots) and
uncertain endogenous (observed in more than 5% of the
spots) together with previously published information
on human tissue expression of each CK. The corre-
sponding frequencies in the mouse study are also
shown. Thirteen CK’s were either not detected at all in
any spot or found in less than 5% of the spots in the
human study; CK’s 3, 4, 7, 8, 11, 12, 13, 15, 17, 18, 19,
20 and 23 correlating with the mouse study (<5%). Eight
CK’s were identified in more than 5% of the human
samples; CK’s 1, 2e, 5, 6A, 9, 10, 14 and 16. These were
also seen often in the mouse study except for CK5,
which was observed with a frequency of 3%. There were
no differences between the CK expression in the human
and mouse study in the combined groups (p = 0.51), the
group of very likely endogenous (p = 0.34) or the group
of uncertain endogenous (p = 0.72). We expected to
Table 1 Frequency of human cytokeratins identified in spots from 2D-PAGE in a human corneal study and mouse
thymic lymphoma study
CKs Type I(acidic)/II(neutral
or basic)
Previously described in human non-
tumour-tissue
Previously described in ocular
epithelium
Location
1 Total count in 102 mouse
spots - %
Very likely endogenous (observed in <5% of human samples)
3 II Cornea
19,17 B0 %
4 II Sebaceous glands, airway epithelium
19 Conjunctiva
17, cornea
5 B4 %
7 II Glands
19 Central basal cornea
17No
found
20
-0 %
8 II Glands
19 Cornea
21, conjunctiva
17 -0 %
11 I Epidermis
19 -0 %
12 I Cornea
19,2 C0 %
13 I Glands, airway epithelium
19,2 Conjuntiva
25, cornea
5 B2 %
15 I Basal keratinocytes
2 Limbal basal
7 L2 %
17 I Hair follicle, nails
2 Cornea
17 -0 %
18 I Glands, simple epithelium
19,2 Cornea
21 -0 %
19 I Glands, airway epithelium
19 Conjunctiva
4, basal limbus
2 L0 %
20 I Gastrointestinal tract epithelium
2 -0 %
23 I Non (found in pancreatic tumours)
22 -0 %
Uncertain endogenous (observed in >5% of human samples)
1 II Epidermis
19 B 36%
2e II Epidermis
19 B 78%
5 II Epidermis, glands, airway epithelium,
hair follicles
19
Conjuntiva
25, cornea
19, 24 B3 %
6A II Glands, airway epithelium, hair
follicles
19
B 27%
9 I Palmoplantar epidermis
2 B 99%
10 I Epidermis
19 B 75%
14 I Epidermis, glands, airway epithelium,
hair follicles
19
Conjuntiva
25, cornea
17 B 18%
16 I Epidermis
19 Cornea
4 B6 %
1Location: C, central fraction, L, limbal fraction, B, both limbal and central fraction.
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mouse study since several of these proteins, in addition
to the expression in the human corneal epithelium, also
are found in skin, hair and other tissues, largely explain-
ing the source of contamination from the laboratory
environment. Table 2 shows the theoretical and observed
molecular mass (M) and pI of each very likely endogen-
ous CK that was identified in the human study. In gen-
eral, a higher observed molecular mass than theoretical
molecular mass may indicate post-translational
modification, the protein is a precursor or alternatively a
contaminant. A lower observed molecular mass than the-
oretical molecular mass is likely to be a cleavage product.
The observed molecular masses listed in Table 2 are lar-
gely equal to or below the theoretical masses. The cover-
age of each observed CK in the likely endogenous group
is shown in Table 2 together with the coverage from the
first amino acid in the most N-terminal identified peptide
to the last amino acid in the most C-terminal identified
peptide in the protein. In none of the cases do we find
Figure 1 2D-gels (A:12%; B:6%) from the limbal fraction shows the significant spots (marked with the SSP number). The approximate pI
and molecular mass is indicated on the axes. SSP No. 0103 and 1205 were not expressed on this gel (B:6%).
Table 2 Characterization of some very likely endogenous cytokeratins
CKs Spot number in gels
(6%=’,12%=*)
UniProtKB/
Swiss-Prot
Observed M
(kDA)
Theoretical M
(kDA)
Observed
pI
Theoretical
pI
Coverage
(%)
Fraction of protein
covered (%)
1
3 6503’ K2C3_HUMAN 64 64.5 6.90 6.12 12 56
5213* P12035 28 6.60 3 34
5610* 60 7.00 31 88
5713* 80 7.05 9 56
4 8402’ K2C4_HUMAN 62 57.3 7.80 6.25 6 21
5602’ P19013 65 6.70 4 57
5610* 60 7.00 3 24
12 0201’ K1C12_HUMAN
Q99456
51 53,4 4.30 4.70 9 40
13 0301’ K1C13_HUMAN 56 49.6 4.40 4.91 25 71
1205’ P13646 56 4.80 35 71
1617* 50 5.05 16 64
1618* 50 5.10 34 90
2402* 38 5.50 5 19
15 2201’ K1C15_HUMAN
P19012
52 49.2 5.60 4.71 16 78
19 2513* K1C19_HUMAN 39 44.1 5.40 5.04 23 81
1517* P08727 40 5.30 17 81
1This was determined by calculating the fraction of the protein covered from the first amino acid in the most N-terminal peptide to the last amino acid in the
most C-terminal peptide observed.
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than in accordance with the observed molecular mass, in
keeping with the identifications being very likely endo-
genous. Identifications tend to be more reliable when the
sequence coverage is large or based on a few high quality
spectra. Only identifications “in bold red” were included
(see above).
Very likely endogenous CK’s
Among the CK’s observed in less than 5% of the human
samples, CK 15 (49 kDa) was identified in one spot
from the limbal epithelial fraction in the 50-kDa area.
The proteomic identification was confirmed by immu-
nohistochemical staining (Figure 2A). Indeed, CK 15 has
recently been found in the basal limbal epithelium [7].
CK 19 (44 kDa) was identified in 2% of the spots, all
focused in the 40-kDa area in the limbal epithelial frac-
tions (Figure 1). CK 19 is a well-characterized marker
for basal limbal epithelial cells (Figure 2B), and is
furthermore found in simple epithelia and epidermal
appendages [2,5,17]. CK 15 and CK 19 were regarded as
very likely endogenous because of the distinct expres-
sion in only the limbal fraction, and also because they
were identified in only a few spots (<2%). In addition,
both proteins were identified by peptides covering
around 80% of the protein as defined by the most
N-terminal to the most C-terminal peptides observed
(Table 2, Figure 3A). Human CK 15 was also observed
in two mouse samples. CK 15 is known to be expressed
in basal epithelia and hair follicle cells [18], which thus
are likely to be rare contaminants in the laboratory
environment.
CK 3 and CK 12 were identified in 4% and 1% of the
human samples respectively and are both specific mar-
kers for differentiated corneal epithelial cells (Figure 2C)
[5,17,19]. A mass spectrum from a 28-kDa spot identi-
fied CK3 by two peptides from the C-terminal of the
protein (64.5 kDa) and thereby could be an identifica-
tion of an endogenous protein. However, we cannot
exclude that this is a cleaved contaminating protein
introduced before electrophoresis (Figure 3B).
CK 4 and CK 13 were identified in 3% and 5% of the
spots in the human set. Both proteins have previously
been identified in the ocular surface (immunohisto-
chemically), in addition to dermal glands and airway
epithelium [2,5,19]. A 60-kDa spot was identified as CK
4 by two peptides in the C-terminal part of the protein
(Figure 3C). This could be a cleaved endogenous pro-
tein, however, contamination cannot be excluded. CK 4
and CK13 were observed in 4 and 2 samples in the
mouse study respectively, indicating that they may be
rare contaminants.
Some of the keratins were rarely identified, some were
not observed and among these some have to our
knowledge not been reported to be localized in the cor-
nea, i.e. CKs 11, 20 and 23 (table 1). Thus, if identified,
they would be very likely endogenous CK’s [20-22].
Uncertain endogenous CK’s
CK 16 appeared in 6% of the spots in both the human
and the mouse study. It is expressed in palmoplantar
epidermis, in epidermal appendage and in mucosa
[2,19,23]. However, CK 16 has also been shown to be
expressed in corneal epithelium to a minor extent [4].
None of the mass spectra proved useful in determining
the origin of the contamination (data not shown).
CK 5 and CK 14 are paired CK’s and were present in
12% and 19% of the samples respectively. CK 5 and CK
14 have previously been found in the corneal epithelium
[17,24], however, they are also present in basal keratino-
cytes in epidermis [2,19,23]. Therefore, most of the
identified CK 5 and CK 14 are considered as contami-
nants, though a few of the identifications could be
endogenous.
CK 6A was identified in 22% of the spots and was
most likely a contaminant. CK 6A is expressed in pal-
moplantar epidermis, epidermal appendage and mucosa
[2,19,23]. Again, none of the mass spectra aided in
determining the origin of the contamination (data not
shown).
CK’s 1, 2e, 9 and 10 were identified in more than 73%
of the human spots. Figure 3D shows the peptide-
sequence leading to identification of CK 9 in a spot
focused at around 10 kDa in the gel. Fragments of pep-
tides were identified throughout the whole protein
(62 kDa). It entails that the identification was based not
only on a 10-kDa fragment, but rather on the whole
protein. This can only be explained by contamination
with an un-cleaved protein located on the surface of the
excised spot or contamination introduced into the sam-
ple prior to enzymatic digestion. All 4 keratins are abun-
dantly expressed in suprabasal cells of stratified and
cornified epithelia or palmoplantar epidermis [2,19,23],
but not in the corneal epithelium [4,17,25]. CK’s 1, 2e, 9
and 10 are all considered to be contaminating. This is
consistent with previous reports [26,27].
Aspects of contamination
Contamination of CK’s occur principally during sample
collection or gel preparation and excision. Indeed, by our
scraping method there is a risk of contaminating the lim-
bal epithelial fraction by conjunctival epithelium. Immu-
nohistochemistry is especially effective in revealing this
type of contamination [13]. If contamination occurs dur-
ing sample collection and preparation prior to loading on
the gels, the contaminating CK’s may be focused as spots
in the gels. If the contamination occurs during the pre-
paration of the gel solutions, gel casting, spot excision or
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taminants may appear as identified proteins with molecu-
lar masses not in accordance with the spot position.
Impact of the number of investigated spots
The total number of investigated spots is important in
this set-up. The more frequent a CK is identified the
more likely it is to be a contaminant. However, it should
also be considered that endogenous CK’st h a th a v es e v -
eral isoforms or have undergone degradation could
erroneously be interpreted as contamination and be
excluded from the investigation.
Optimization of the method
In a proteomic screening experiment, it may be desir-
able to obtain as many protein candidates as possible if
specific validation techniques are to be subsequently
undertaken. An important issue is how much of the
sample should be loaded onto the gel. Overloaded gels
may lead to increased spot size that can merge with
Figure 2 Immunohistochemical staining against various antigens.( A) CK 15 and (B) CK 19 appear in the limbal epithelium. (C) CK 3/CK 12
stainings in central corneal epithelium.
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difficult and inaccurate. Conversely, if an inadequate
amount of sample is loaded onto the gel, the relative
amount of contaminating proteins will tend to increase.
In the present study, a relatively small amount of pro-
tein was loaded, in an effort to preserve the resolution
of proteins in the 40-60 kDa range where gel spots have
a tendency to merge together. However, despite the gels
produced well-focused spots with low background
staining the number of successful identifications was
lower than expected, probably as a result of the rela-
tively small amount of protein loaded and the relatively
high frequency of contaminating CK’s.
Conclusions
It is very important to consider possible contamination of
CK’s when undertaking MS based proteomic screening
experiments, especially with regard to studies of the
A) 
     1 MTSYSYRQSS ATSSFGGLGG GSVRFGPGVA FRAPSIHGGS GGRGVSVSSA 
    51 RFVSSSSSGG YGGGYGGVLT ASDGLLAGNE KLTMQNLNDR LASYLDKVRA 
   101 LEAANGELEV KIRDWYQKQG PGPSRDYSHY YTTIQDLRDK ILGATIENSR 
   151 IVLQIDNARL AADDFRTKFE TEQALRMSVE ADINGLRRVL DELTLARTDL 
   201 EMQIEGLKEE LAYLKKNHEE EISTLRGQVG GQVSVEVDSA PGTDLAKILS 
   251 DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR 
   301 RTLQGLEIEL QSQLSMKAAL EDTLAETEAR FGAQLAHIQA LISGIEAQLG 
   351 DVRADSERQN QEYQRLMDIK SRLEQEIATY RSLLEGQEDH YNNLSASKVL 
   401 
B) 
     1 MSRQASKTSG GGSQGFSGRS AVVSGSSRMS CVAHSGGAGG GAYGFRSGAG 
    51 GFGSRSLYNL GGNKSISISV AAGGSRAGGF GGGRSSCAFA GGYGGGFGSG 
   101 YGGGFGGGFG GGRGMGGGFG GAGGFGGAGG FGGAGGFGGP GGFGGSGGFG 
   151 GPGSLGSPGG FGPGGFPGGI QEVTINQSLL QPLNVEIDPQ IGQVKAQERE 
   201 QIKTLNNKFA SFIDKVRFLE QQNKVLETKW NLLQQQGTSS ISGTNNLEPL 
   251 FENHINYLRS YLDNILGERG RLDSELKNME DLVEDFKKKY EDEINKRTAA 
   301 ENEFVTLKKD VDSAYMNKVE LQAKVDALID EIDFLRTLYD AELSQMQSHI 
   351 SDTSVVLSMD NNRSLDLDSI IAEVRAQYED IAQRSKAEAE ALYQTKLGEL 
   401 QTTAGRHGDD LRNTKSEIIE LNRMIQRLRA EIEGVKKQNA NLQTAIAEAE 
   451 QHGEMALKDA NAKLQELQAA LQQAKDDLAR LLRDYQELMN VKLALDVEIA 
   501 TYRKLLEGEE YSRMSGECPS AVSISVVSSS TTSASAGGYG GGYGGGMGGG 
   551 LGGGFSAGGG SGSGFGRGGG GGIGGGFGGG SSGFSGGSGF GSISGARYGV 
   601 SGGGFSSASN RGGSIKFSQS SQSSQRYSR 
C) 
     1 MIARQQCVRG GPRGFSCGSA IVGGGKRGAF SSVSMSGGAG RCSSGGFGSR 
    51 SLYNLRGNKS ISMSVAGSRQ GACFGGAGGF GTGGFGAGGF GAGFGTGGFG 
   101 GGFGGSFSGK GGPGFPVCPA GGIQEVTINQ SLLTPLHVEI DPEIQKVRTE 
   151 EREQIKLLNN KFASFIDKVQ FLEQQNKVLE TKWNLLQQQT TTTSSKNLEP 
   201 LFETYLSVLR KQLDTLGNDK GRLQSELKTM QDSVEDFKTK YEEEINKRTA 
   251 AENDFVVLKK DVDAAYLNKV ELEAKVDSLN DEINFLKVLY DAELSQMQTH 
   301 VSDTSVVLSM DNNRNLDLDS IIAEVRAQYE EIAQRSKAEA EALYQTKVQQ 
   351 LQISVDQHGD NLKNTKSEIA ELNRMIQRLR AEIENIKKQC QTLQVSVADA 
   401 EQRGENALKD AHSKRVELEA ALQQAKEELA RMLREYQELM SVKLALDIEI 
   451 ATYRKLLEGE EYRMSGECQS AVSISVVSGS TSTGGISGGL GSGSGFGLSS 
   501 GFGSGSGSGF GFGGSVSGSS SSKIISTTTL NKRR 
 
D) 
     1 MSCRQFSSSY LSRSGGGGGG GLGSGGSIRS SYSRFSSSGG GGGGGRFSSS 
    51 SGYGGGSSRV CGRGGGGSFG YSYGGGSGGG FSASSLGGGF GGGSRGFGGA 
   101 SGGGYSSSGG FGGGFGGGSG GGFGGGYGSG FGGFGGFGGG AGGGDGGILT 
   151 ANEKSTMQEL NSRLASYLDK VQALEEANND LENKIQDWYD KKGPAAIQKN 
   201 YSPYYNTIDD LKDQIVDLTV GNNKTLLDID NTRMTLDDFR IKFEMEQNLR 
   251 QGVDADINGL RQVLDNLTME KSDLEMQYET LQEELMALKK NHKEEMSQLT 
   301 GQNSGDVNVE INVAPGKDLT KTLNDMRQEY EQLIAKNRKD IENQYETQIT 
   351 QIEHEVSSSG QEVQSSAKEV TQLRHGVQEL EIELQSQLSK KAALEKSLED 
   401 TKNRYCGQLQ MIQEQISNLE AQITDVRQEI ECQNQEYSLL LSIKMRLEKE 
   451 IETYHNLLEG GQEDFESSGA GKIGLGGRGG SGGSYGRGSR GGSGGSYGGG 
   501 GSGGGYGGGS GSRGGSGGSY GGGSGSGGGS GGGYGGGSGG GHSGGSGGGH 
   551 SGGSGGNYGG GSGSGGGSGG GYGGGSGSRG GSGGSHGGGS GFGGESGGSY 
   601 GGGEEASGSG GGYGGGSGKS SHS 
Figure 3 Peptide sequences from the Mascot search results. A: CK 19 identified in a 39-kDa spot by 7 peptides (Matched peptides shown in
bold red). It is most likely an endogenous protein although a contaminating protein cannot be excluded. B: Two peptides (24 amino acids)
identify CK 3 from a spot focused around 28 kDa. This could be an endogenous protein or it could be due to contamination of the samples.
C: Two peptides (20 amino acids) identify CK 4 from a spot focused around 60 kDa. This could be an endogenous protein or it could be a
contamination of the samples. D: CK 9 identified by the matched peptides throughout the whole protein. Since the sample originates from a
spot focused around 10 kDa in the gel the protein is regarded as a contaminant.
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search for differences in protein expression, including
CK’s, careful consideration should be applied to the sam-
ple amount chosen. Generally one should load as much
sample as possible, to the point of not compromising 2D-
gel spot resolution. We have shown that if several 2D-gel
spots are being processed, CK’s represented in less than
5% percent of the spots are very likely to be endogenous
identifications (CK’s 3, 4, 7, 8, 11, 12, 13, 15, 17, 18, 19,
20 and 23). If a CK is identified in a large part of the sam-
ples it is an uncertain endogenous CK (CK’s 1, 2e, 5, 6A,
9, 10, 14 and 16). Confirmation of the CK identification
by other biochemical methods such as immunohisto-
chemistry is also very important.
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